Safety of Assisted Reproductive Technology in the United States, 2000-2011
Author(s) -
Jennifer F. Kawwass,
Dmitry M. Kissin,
Aniket Kulkarni,
Andreea A. Creanga,
Donna R. Session,
William M. Callaghan,
Denise J. Jamieson
Publication year - 2015
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2014.14488
Subject(s) - medicine , assisted reproductive technology , family medicine , pregnancy , infertility , genetics , biology
Use of assisted reproductive technology (ART) continues to increase in the United States and globally. In an effort to improve patient safety, stimulation protocols have become less aggressive, oocyte retrieval has transitioned from laparoscopic to transvaginal, and pregnancy rates have improved.1 However, limited data exist regarding the incidence of maternal complications.2 We explored incidence and trends in reported patient and donor complications in fresh ART cycles using the US Centers for Disease Control and Prevention National ART Surveillance System (NASS).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom